|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$24,511,741 |
|
|
Indirect Value
|
$3,299,393 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-12 |
4 |
AS |
$85.00 |
$3,225,000 |
D/D |
(37,500) |
28,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-23 |
4 |
OE |
$86.52 |
$503,892 |
D/D |
5,824 |
44,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-06-29 |
4 |
OE |
$86.52 |
$364,148 |
D/D |
4,096 |
50,758 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-03 |
4 |
OE |
$86.52 |
$168,022 |
D/D |
1,942 |
48,604 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-05 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
48,603 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2019-02-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-10-22 |
4 |
OE |
$86.52 |
$335,957 |
D/D |
3,883 |
37,299 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
37,513 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$364,239 |
D/D |
4,097 |
40,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-04 |
4 |
OE |
$86.52 |
$4,942,968 |
D/D |
43,752 |
78,855 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-08-03 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
37,044 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2021-04-27 |
4 |
OE |
$86.52 |
$336,044 |
D/D |
3,884 |
44,017 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-02-13 |
4 |
AS |
$87.68 |
$673,733 |
D/D |
(7,684) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-19 |
4 |
AS |
$88.00 |
$1,973,250 |
D/D |
(22,250) |
28,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-02-03 |
4 |
AS |
$89.91 |
$923,460 |
D/D |
(10,166) |
86,096 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-29 |
4 |
OE |
$91.05 |
$1,373,489 |
D/D |
15,085 |
54,248 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-02-26 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-10-25 |
4 |
OE |
$91.05 |
$392,517 |
D/D |
4,311 |
37,727 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2016-11-15 |
4 |
AS |
$93.36 |
$10,830 |
D/D |
(116) |
86,096 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-03-09 |
4 |
OE |
$96.87 |
$1,331,963 |
D/D |
13,750 |
60,412 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-07-13 |
4 |
OE |
$96.87 |
$1,165,443 |
D/D |
12,031 |
58,693 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-07-16 |
4 |
OE |
$96.87 |
$166,520 |
D/D |
1,719 |
48,381 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-06-24 |
4 |
AS |
$98.03 |
$4,141,768 |
D/D |
(42,250) |
38,671 |
0 |
- |
|
193 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|